Skip to content

Validation of a Precision Screening Model for Plasma Cell Diseases Based on Routine Biochemical Parameters

Validation of a Precision Screening Model for Plasma Cell Diseases Based on Routine Biochemical Parameters

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115208
Enrollment
Unknown
Registered
2025-12-23
Start date
2025-12-29
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple myeloma (MM)

Interventions

M-protein negative group:None

Sponsors

Southern Medical University Southern Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria for the M-protein positive group: 1. Age >= 18 years old; 2. Signed informed consent; 3. Visited Southern Hospital of Southern Medical University from January 2023 to July 2024 and did not return for subsequent medical visits; 4. Patients diagnosed as M-protein positive by capillary immunotyping electrophoresis and/or agarose immunofixation electrophoresis. Inclusion criteria for the M-protein negative group: 1. Age >= 18 years old; 2. Signed informed consent; 3. Visited Southern Hospital of Southern Medical University from January 2023 to July 2024 and did not return for subsequent medical visits; 4. Patients determined to be M-protein negative based on capillary immunotyping electrophoresis and/or agarose immunofixation electrophoresis.

Exclusion criteria

Exclusion criteria: 1.Cases with incomplete subject information or those not fully collected for other reasons.

Design outcomes

Primary

MeasureTime frame
Total Protein;Specificity;

Countries

China

Contacts

Public ContactLi Xin

Southern Medical University Southern Hospital

littlesnial@163.com+86 20 6164 2140

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026